N4 Pharma PLC
F:0GO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N4 Pharma PLC
F:0GO
|
UK |
|
S
|
Sparc AI Inc
CNSX:SPAI
|
AU |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
T
|
Techbond Group Bhd
KLSE:TECHBND
|
MY |
|
C
|
China Citic Bank Corp Ltd
XMUN:D7C
|
CN |
|
A
|
Aluminum Corporation of China Ltd
SWB:AOC
|
CN |
|
D
|
Daiichi Sankyo Co Ltd
DUS:D4S
|
JP |
|
Odyssey Gold Ltd
ASX:ODY
|
AU |
|
H
|
Hope Bancorp Inc
F:NRB
|
US |
|
Julius Baer Gruppe AG
OTC:JBARF
|
CH |
|
E
|
Elekta AB (publ)
DUS:EJXB
|
SE |
|
E
|
Easterly Government Properties Inc
F:E05
|
US |
|
R
|
Renault SA
XMUN:RNL
|
FR |
|
Burckhardt Compression Holding AG
F:B5H
|
CH |
|
COSCIENS Biopharma Inc
NASDAQ:CSCI
|
CA |
|
T
|
TopBuild Corp
BMV:BLD
|
US |
|
Dusk Group Ltd
F:6EA
|
AU |
|
A
|
Air China Ltd
XMUN:AD2
|
CN |
Bankruptcy Probability
N4 Pharma PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
N4 Pharma PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
N4 Pharma PLC
LSE:N4P
|
3.7m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
611.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
310.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
354.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
N4 Pharma PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, N4 Pharma PLC has no debt.
You can find a full breakdown on its Balance Sheet.
